These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26490350)

  • 21. Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.
    Irvine MA; Reimer LJ; Njenga SM; Gunawardena S; Kelly-Hope L; Bockarie M; Hollingsworth TD
    Parasit Vectors; 2015 Oct; 8():547. PubMed ID: 26489753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
    Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
    Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector?
    Stone CM; Lindsay SW; Chitnis N
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3393. PubMed ID: 25501002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
    Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
    Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy.
    Prada JM; Touloupou P; Kebede B; Giorgi E; Sime H; Smith M; Kontoroupis P; Brown P; Cano J; Farkas H; Irvine M; Reimer L; Caja Rivera R; de Vlas SJ; Michael E; Stolk WA; Pulan R; Spencer SEF; Hollingsworth TD; Seife F
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S117-S125. PubMed ID: 38662702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic filariasis: Treatment, control and elimination.
    Ottesen EA
    Adv Parasitol; 2006; 61():395-441. PubMed ID: 16735170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GEOFIL: A spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic filariasis in American Samoa.
    Xu Z; Graves PM; Lau CL; Clements A; Geard N; Glass K
    Epidemics; 2019 Jun; 27():19-27. PubMed ID: 30611745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
    Rebollo MP; Bockarie MJ
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):723-31. PubMed ID: 23879610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can community-based integrated vector control hasten the process of LF elimination?
    Sunish IP; Kalimuthu M; Kumar VA; Munirathinam A; Nagaraj J; Tyagi BK; White GB; Arunachalam N
    Parasitol Res; 2016 Jun; 115(6):2353-62. PubMed ID: 26969179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.
    Khan AM; Dutta P; Sarmah CK; Baruah NK; Das S; Pathak AK; Sarmah P; Hussain ME; Mahanta J
    J Vector Borne Dis; 2015 Dec; 52(4):314-20. PubMed ID: 26714512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population migration: implications for lymphatic filariasis elimination programmes.
    Ramaiah KD
    PLoS Negl Trop Dis; 2013; 7(3):e2079. PubMed ID: 23556008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modelling and the control of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Simonsen PE; Pedersen EM; Barker G; Kumar A; Kazura JW
    Lancet Infect Dis; 2004 Apr; 4(4):223-34. PubMed ID: 15050941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village.
    Hapairai LK; Plichart C; Naseri T; Silva U; Tesimale L; Pemita P; Bossin HC; Burkot TR; Ritchie SA; Graves PM; Melrose W; Joseph H
    Parasit Vectors; 2015 May; 8():287. PubMed ID: 26016830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping, bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa.
    Slater H; Michael E
    PLoS One; 2013; 8(8):e71574. PubMed ID: 23951194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current practices in the management of lymphatic filariasis.
    Bockarie MJ; Taylor MJ; Gyapong JO
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):595-605. PubMed ID: 19485799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.